Dataset from An Asian, Multicenter, Randomized, Double-blind, Placebo-controlled, 14-week Study of Mirogabalin in Participants With Central Neuropathic Pain Followed by a 52-week, Open-label Extension
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009959
下载链接
链接失效反馈官方服务：
资源简介：
Investigate the efficacy and safety of mirogabalin in participants with central neuropathic
pain in comparison to placebo
创建时间：
2025-02-10
